Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Aspergillosis

Clinical Trial Details

Overview

Research Study Summary

Patients are needed to participate in a clinical research study of caspofungin to evaluate Invasive Pulmonary Aspergillosis or Chronic Obstructive Pulmonary Disease

Research Study Title

Prospective, Open-label Study of the Efficacy and Safety of Caspofungin for the Treatment of Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease

Purpose

The investigators propose to study the efficacy and safety of three-week antifungal therapy with caspofungin in hospitalized patients with proven or probable IPA underlying chronic obstructive pulmonary disease.

To Learn more
Phase

4

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Lead Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Duration

32 Months

Facility Type

N/A

Eligibility

Both Male and Female ages 18 Years and up

Inclusion Criteria:

  • Proven invasive pulmonary aspergillosis

  • Probable invasive pulmonary aspergillosis

  • Hospitalized in respiratory wards

  • Not having received an empirical antifungal therapy for 72h before inclusion

Exclusion Criteria:

  • A history of allergy to echinocandins

  • Severe renal failure, severe hepatic insufficiency

  • Inadequately treated bacterial infection

  • Documented HIV infection

  • Status of pregnancy or lactation

Site Locations (1)

Country State City Zip Facility and Contact
China Guangdong Guangzhou 510120 Guangzhou Institute of Respiratory Diseases
Nanshan Zhong, MD
862083062888
Nanshan@vip.163.com

Feng Ye, MD
Principal Investigator

Contact

Feng Ye, MD
862083062836

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

NCT ID: NCT01499433

Date Last Changed: January 22, 2014

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.